Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Elston GeorgeChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · derivative · entry 5 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-09 F5 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Elston GeorgeChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 17,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · derivative · entry 4 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires not disclosed F4 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F4 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Elston GeorgeChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · derivative · entry 3 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F3 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Elston GeorgeChief Financial Officer
|
Tax withholdingCommon Stock | 1,721 | $10.13 | $17,433.73 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · nonDerivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Elston GeorgeChief Financial Officer
|
Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 739 shares acquired on January 29, 2021, 648 shares acquired on July 30, 2021 and 970 shares acquired on January 31, 2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:53 UTC |
DICICCO WENDY FDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001418 · primarydocument.xml · derivative · entry 4 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2032-02-09 F2 · derivative.exercise_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:53 UTC |
DICICCO WENDY FDirector
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001418 · primarydocument.xml · derivative · entry 3 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_date: Will fully vest on the one-year anniversary of the grant date. F2 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:53 UTC |
DICICCO WENDY FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001418 · primarydocument.xml · derivative · entry 2 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested on the one-year anniversary of the grant date. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:53 UTC |
DICICCO WENDY FDirector
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001418 · primarydocument.xml · nonDerivative · entry 1 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
GUYER DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001419 · primarydocument.xml · derivative · entry 4 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 11,000 shares Expires 2032-02-09 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
GUYER DAVID RDirector
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001419 · primarydocument.xml · derivative · entry 3 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_date: Will fully vest on the one-year anniversary of the grant date. F2 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
GUYER DAVID RDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001419 · primarydocument.xml · derivative · entry 2 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested on the one-year anniversary of the grant date. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
GUYER DAVID RDirector
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001419 · primarydocument.xml · nonDerivative · entry 1 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Duker Jay S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001414 · primarydocument.xml · derivative · entry 4 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2032-02-09 F3 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Duker Jay S.Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001414 · primarydocument.xml · derivative · entry 3 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F2 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Duker Jay S.Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 21,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001414 · primarydocument.xml · derivative · entry 2 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC |
Duker Jay S.Chief Operating Officer
|
Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001414 · primarydocument.xml · nonDerivative · entry 1 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC |
Paggiarino Dario A.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · derivative · entry 5 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-09 F4 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · derivative · entry 4 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F3 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC |
Paggiarino Dario A.Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 17,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F2 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 1,721 | $10.13 | $17,433.73 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,840 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2022 Filed Jan 14, 2022 19:14 UTC |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $12.62 | $0.00 |
DisclosureSEC source: 0001562180-22-000469 · primarydocument.xml · derivative · entry 1 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-01-10 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:03 UTC |
Lurker NancyDirector · President & CEO
|
SaleCommon Stock | 10,000 | $20.15 | $201,480.00 |
DisclosureSEC source: 0001562180-21-007116 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.765. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 17:54 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001562180-21-006809 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 21:50 UTC |
Duker Jay S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 305,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001562180-21-006808 · primarydocument.xml · derivative · entry 2 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,000 Underlying: Common Stock · 305,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 21:50 UTC |
Duker Jay S.Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 15,258 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-006808 · primarydocument.xml · derivative · entry 1 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,258 Underlying: Common Stock · 15,258 shares Expires 2031-11-01 Read SEC document |
| November 01, 2021 Filed Sep 9, 2022 20:09 UTC Amendment |
Duker Jay S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 239,700 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001562180-22-006580 · primarydocument.xml · derivative · entry 1 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,700 Underlying: Common Stock · 239,700 shares Expires 2031-11-01 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. F2 · balance_after: Due to an administrative error, the Reporting Person's previous Form 4 filed on November 3, 2021 incorrectly reported the Reporting Person receiving an option grant of 305,000 shares of common stock when it should have been reported as 239,700 shares of common stock. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:29 UTC |
ANDO GORANDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004455 · primarydocument.xml · derivative · entry 2 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-02-09 Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:29 UTC |
ANDO GORANDirector
|
GrantRestricted Stock Units · Derivative | 2,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004455 · primarydocument.xml · derivative · entry 1 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires not disclosed F1 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:28 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,300 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004453 · primarydocument.xml · derivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,300 Underlying: Common Stock · 60,300 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:28 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 14,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004453 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,005 Underlying: Common Stock · 14,900 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:30 UTC |
Landis John B.Director
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004457 · primarydocument.xml · derivative · entry 2 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:30 UTC |
Landis John B.Director
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004457 · primarydocument.xml · derivative · entry 1 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F1 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:27 UTC |
Lurker NancyDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 213,700 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004451 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,700 Underlying: Common Stock · 213,700 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:27 UTC |
Lurker NancyDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 52,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004451 · primarydocument.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,600 Underlying: Common Stock · 52,600 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:27 UTC |
Elston GeorgeChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,300 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004452 · primarydocument.xml · derivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,300 Underlying: Common Stock · 60,300 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:27 UTC |
Elston GeorgeChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 14,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004452 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,900 Underlying: Common Stock · 14,900 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:39 UTC |
Godshall Douglas EvanDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004459 · primarydocument.xml · derivative · entry 3 Godshall Douglas Evan · CIK 0001404227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2023-06-22 F1 · date: The grants were approved by the Compensation Committee on February 9, 2021, subject to stockholder approval of an amendment to increase the number of shares in the Company's 2016 Plan. The shareholders approved the amendment on June 22, 2021. F3 · derivative.exercise_date: The option to purchase vested immediately upon Mr. Godshall's departure from the Board on June 22, 2021. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:39 UTC |
Godshall Douglas EvanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004459 · primarydocument.xml · derivative · entry 2 Godshall Douglas Evan · CIK 0001404227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The grants were approved by the Compensation Committee on February 9, 2021, subject to stockholder approval of an amendment to increase the number of shares in the Company's 2016 Plan. The shareholders approved the amendment on June 22, 2021. F2 · derivative.exercise_date: The Restricted Stock grant vested immediately upon Mr. Godshall's departure from the Board on June 22, 2021. F2 · derivative.expiration_date: The Restricted Stock grant vested immediately upon Mr. Godshall's departure from the Board on June 22, 2021. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:39 UTC |
Godshall Douglas EvanDirector
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004459 · primarydocument.xml · nonDerivative · entry 1 Godshall Douglas Evan · CIK 0001404227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:29 UTC |
DICICCO WENDY FDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004456 · primarydocument.xml · derivative · entry 2 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:29 UTC |
DICICCO WENDY FDirector
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004456 · primarydocument.xml · derivative · entry 1 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F1 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:30 UTC |
GUYER DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004458 · primarydocument.xml · derivative · entry 2 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:30 UTC |
GUYER DAVID RDirector
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004458 · primarydocument.xml · derivative · entry 1 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F1 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:28 UTC |
Paggiarino Dario A.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,300 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004454 · primarydocument.xml · derivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,300 Underlying: Common Stock · 60,300 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:28 UTC |
Paggiarino Dario A.Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 14,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004454 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,900 Underlying: Common Stock · 14,900 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004275 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vests in three annual installments beginning on 14-Jun-2019 F1 · derivative.expiration_date: Vests in three annual installments beginning on 14-Jun-2019 Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004275 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,420 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004274 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vests in three annual installments beginning on 14-Jun-2019 F2 · derivative.expiration_date: Vests in three annual installments beginning on 14-Jun-2019 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.